Track LigaChem Biosciences Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

LigaChem Biosciences Inc. 141080.KQ Open LigaChem Biosciences Inc. in new tab

150300.00 KRW
ROE
-15.82
Beta
0.50
Target Price
228333.33 KRW
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 18, 2026
Debt/Equity0.51
% Insiders29.273%
Growth
Revenue Growth-0.53%
Estimates
Forward P/E101.17
Target Mean Price228333.33

DCF Valuation

Tweak assumptions to recompute fair value for LigaChem Biosciences Inc. (141080.KQ)
Currency: KRW
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

LigaChem Biosciences Inc. Logo LigaChem Biosciences Inc. Analysis (141080.KQ)

South Korea Healthcare Official Website Stock

Is LigaChem Biosciences Inc. a good investment? LigaChem Biosciences Inc. (141080.KQ) is currently trading at 150300.00 KRW. Market analysts have a consensus price target of 228333.33 KRW. This suggests a potential upside from current levels.

Earnings Schedule: LigaChem Biosciences Inc. is expected to release its next earnings report on Aug. 18, 2026.

Investor FAQ

Does LigaChem Biosciences Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is LigaChem Biosciences Inc.?

LigaChem Biosciences Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 18, 2026.

Company Profile

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.

Exchange Ticker
KOE 141080.KQ

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
June 16, 2020 2.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion